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Abstract: The aim of this study was to characterize a collection of methicillin-resistant Staphylococcus
aureus (MRSA) isolates of human and animal origin from Serbia. In total, 36 MRSA isolates—30
obtained from humans and six from companion animals—were investigated by PCR for the presence of
antibiotic and biocide resistance determinants and virulence genes (PVL—Panton–Valentine leukocidin,
ETs—exfoliative toxins, TSST—toxic shock syndrome toxin, SEs—staphylococcal enterotoxins, and
MSCRAMMs—microbial surface components recognizing adhesive matrix molecules and biofilm).
Isolates were analyzed by staphylococcal cassette chromosome mec (SCCmec), spa, and dru typing, as
well as by multiple locus variable number of tandem repeat analyses (MLVA), multilocus sequence
typing (MLST), and subsequently, eBURST. The majority of human MRSA isolates were resistant to
gentamicin, erythromycin, clindamycin, and ciprofloxacin. Different antibiotic resistance genes were
detected: aac-aphD, ant(6′)-Ia, erm(A), erm(B), erm(C), tet(K), tet(M), fexA, and catpC221. All isolates were
susceptible to teicoplanin and linezolid. SCCmec type III was prevalent in human isolates, while SCCmec
elements in animals were mostly nontypeable. t037 was the predominant spa type in human and t242 in
animal MRSA isolates. The prevalent dru type was dt11c in human and dt10a in animal MRSA isolates.
MRSA isolates exhibited 27 different MLVA types. ST239 was predominant in human, while ST5 was
prevalent in canine MRSA isolates. PVL was found in two, while tsst-1 was detected in three human
isolates. Human-associated clones belonging to ST5, ST45, and ST239 MRSA clones were discovered in
companion animals, which suggests anthropozoonotic transmission.
Keywords: MRSA; humans; animals; antibiotic resistance; SCCmec typing; dru typing; spa typing;
MLVA; MLST
1. Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is a well-known and widespread pathogen that
has the ability to cause a wide spectrum of clinical diseases in humans and various animal species [1].
MRSA strains carry a diverse and transmissible genetic element designated as staphylococcal cassette
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chromosome mec (SCCmec) [2]. To date, thirteen major types of SCCmec have been identified, as well
as a number of deletion variants, composite, and irregular elements [3,4]. In MRSA isolates of human
and animal origin, mecA and mecC genes have been detected [5]. MRSA strains are notorious for being
multidrug-resistant [6]. In addition to mec genes, MRSA strains possess many different antibiotic,
heavy metal, and disinfectant resistance genes, as well as virulence determinants that could be located
on SCCmec and SCC elements, but also on the other mobile genetic elements (MGEs) [7].
MRSA is one of the leading causes of hospital-acquired infections. Healthcare-associated MRSA
(HA-MRSA) infections represent a significant burden due to increased morbidity that leads to extended
hospital stays and extra hospitalization costs but also cause higher mortality than methicillin-susceptible
S. aureus (MSSA) [6]. At first, HA-MRSA clones were limited to hospitals and later, multidrug-resistant
HA-MRSA strains moved from hospital settings to the community [6]. By contrast, community-associated
S. aureus (CA-MRSA) emerged in the community, among healthy young individuals with no prior
connections to the healthcare system. CA-MRSA strains often carry genes encoding Panton–Valentin
leukocidin (PVL), which is responsible for severe infections of skin and soft tissue and necrotizing
pneumonia [8]. CA-MRSA strains have become a serious public health problem, as these virulent strains
rapidly spread in the general population and close social groups, causing outbreaks [8].
At present, CA-MRSA strains have shifted from the community to hospitals, where these once
generally susceptible strains have acquired additional antibiotic resistance determinants [9,10].
S. aureus is capable of colonizing skin and mucous membranes of healthy dogs and cats, but
the frequency of S. aureus isolation is low: generally lower than 10% [11]. Prevalence data on MRSA
presence in healthy dogs and cats are variable, but most studies have reported rates of 0–6% [11].
The information on MRSA from Serbia is scarce, mainly reported on the presence and
characterization of MRSA isolates from humans and food animals [12–18], but to date, no study
on MRSA presence in companion animals has been published.
The high proximity of companion animals to humans brings benefits for both. On the other hand,
this proximity could also be associated with transmission in both directions, zoo-antrophogenic and vice
versa, of antibiotic-resistant bacteria such as MRSA. Thus, due to the threat posed on animal and human
health by the emergence of MRSA in humans in Serbia as well as the total scarcity of published data on
MRSA from companion animals, the aim of the present study was to characterize and compare MRSA
isolates originating from unrelated humans and companion animals during a certain point of time in
order to determine any similarity and differences between human and animal MRSA isolates from Serbia.
2. Results
2.1. Antibiotic Susceptibility Testing
All tested MRSA isolates originating from humans (n = 30) were susceptible to teicoplanin and
linezolid, while 25 isolates were resistant to gentamicin and one to amikacin, and the presence of
corresponding gene aac-aphD was revealed in 26 isolates, while the ant(6′)-Ia gene was found in 25 isolates;
22 isolates were resistant to erythromycin and clindamycin (two isolates showed inducible clindamycin
resistance), which was reflected in that carrying erm(A) (7), erm(B) (7), and erm(C) (17) genes. Six isolates
were resistant to tetracycline and the following corresponding genes were detected: tet(K) in 4 and tet(M)
in 21 isolates; four isolates were resistant to chloramphenicol and matching genes fexA and catpC221 were
found in two and four isolates, respectively (Table 1). Resistance to ciprofloxacin was detected in 23
isolates, to rifampin in two, and to trimethoprim–sulfamethoxazole in one isolate. All MRSA isolates
from animals (n = 6) were susceptible to amikacin, trimethoprim–sulfamethoxazole, chloramphenicol,
teicoplanin, and linezolid. Resistance to gentamicin was recorded in three isolates, and the corresponding
aac-aphD gene was detected in four isolates. Resistance to erythromycin and clindamycin (inducible type)
was found in one isolate, and the presence of the matching erm(C) was revealed in that isolate. Resistance
to tetracycline was exhibited by one isolate and in that isolate, corresponding tet(K) and tet(M) genes were
detected. Resistance to ciprofloxacin in was found in two isolates and resistance to rifampin in one isolate,
while the presence of ant(6′)-Ia was in revealed in three isolates (Table 1).
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Table 1. Molecular characterization, antimicrobial resistance, and toxin profile of the methicillin-resistant Staphylococcus aureus isolates investigated.
Antimicrobial Resistance Virulence
FactorsID Host Clinical Site spa dru SCCmec MLVA * ST CC Phenotype ** Genes Detected IEC *** Miscellaneous Genes ****
S264 Cat Skin swab t127 dt7o NT 15 ST1 CC1 β-Lactams, CIP, GEN,RIF
mecA, aacA-aphD,
ant(6’)-la seg
sak, sea,
scn, hlb fnbA, clfA, clfB, icaA
NN Human Wound swab t223 nt IV 18 ST22 CC22 β-Lactams mecA seg, sei, tsst-1,PVL
chp, sak,
scn, hlb fnbA, clfB
S164 Human Sputum t037 dt10a NT 9 ST152 CC152 β-Lactams, CIP, GEN,TET, CHL, ERY, CLI
mecA,aacA-aphD,
ant(6′)-Ia, erm(C), tet(K),
tet(M), catpC221
sea sak, sea,scn, hlb fnbA, clfA, clfB, icaA
S239 Human Nippledischarge t037 dt11c III 5 ST239 CC239
β-Lactams, CIP, GEN,
ERY, CLI
mecA, aacA-aphD,
ant(6′)-Ia, erm(C), tet(M) sea
sak, sea,
scn, hlb fnbA, clfA, clfB, cna, icaA
S241 Human Wound swab t037 dt11c III +SCCmercury 6 ST239 CC239
β-Lactams, CIP, GEN,
TET, ERY, CHL, CLI
mecA, aacA-aphD,
ant(6′)-Ia, erm(C), tet(K),
tet(M), fexA, catpC221
sea sak, sea,scn, hlb fnbA, clfA, clfB, cna, icaA
S245 Human Wound swab t037 dt11c III +SCCmercury 7 ST239 CC239
β-Lactams, CIP, GEN,
AMK, TET, CHL
mecA, aacA-aphD,
ant(6′)-Ia, tet(K), tet(M),
fexA, catpC221
sea sak, sea,scn, hlb fnbA, clfA, clfB, cna, icaA
S246 Human Wound swab t037 dt11c III 8 ne CC239 β-Lactams, CIP, GEN,ERY, CLI
mecA, aacA-aphD,
ant(6′)-Ia, erm(C), tet(M) sea
sak, sea,
scn, hlb fnbA, clfA, clfB, cna, icaA
S255 Human Wound swab t037 dt11c III 8 ne CC239 β-Lactams, CIP, GEN,ERY, CLI
mecA, aacA-aphD,
ant(6′)-Ia, erm(C), tet(M) sea
sak, sea,
scn, hlb fnbA, clfA, clfB, cna, icaA
S257 Human Sputum t037 dt11c III 8 ST239 CC239 β-Lactams, CIP, GEN,ERY, CLI
mecA, aacA-aphD,
ant(6′)-Ia, erm(C) sea
sak, sea,
scn, hlb fnbA, clfA, clfB, cna, icaA
S399 Human Wound swab t037 dr11c NT 10 ST239 CC239 β-Lactams, CIP, GEN mecA, aacA-aphD,ant(6′)-Ia, tet(M) sea, sei
sak, sep,
scn, hlb fnbA, clfA, clfB, cna, icaA
S401 Human Wound swab t037 dr11c NT 11 ne CC239 β-Lactams, CIP, GEN mecA, aacA-aphD,ant(6′)-Ia, tet(M) sea
sak, sep,
scn, hlb fnbA, clfA, clfB, cna, icaA
S473 Human Wound swab t037 dt11c III 11 ne CC239 β-Lactams, CIP, GEN mecA, aacA-aphD,ant(6′)-Ia, tet(M) sea
sak, sea,
scn, hlb fnbA, clfB, cna
S474 Human Wound swab t038 dt11c III 11 ne CC239 β-Lactams, CIP, GEN,ERY, CLI
mecA, aacA-aphD,
ant(6′)-Ia, erm(C), tet(M) sea, sei
sak, sea,
scn, hlb fnbA, clfB, cna
S475 Human Wound swab t039 dt11c III 12 ST239 CC239 β-Lactams, CIP, GEN,ERY, CLI
mecA, aacA-aphD,
ant(6′)-Ia erm(C), tet(M) -
sak, scn,
hlb fnbA, clfB, cna
S476 Human Wound swab t040 dt11c III 11 ne CC239 β-Lactams, CIP, GEN mecA, aacA-aphD,ant(6′)-Ia, tet(M) sea
sak, sea,
scn, hlb fnbA, clfB, cna
S478 Human Wound swab t041 dt11c III 11 ST239 CC239 β-Lactams, CIP, GEN,ERY, CLI
mecA, aacA-aphD,
ant(6′)-Ia, erm(C), tet(M) sea
sak, sea,
scn, hlb fnbA, clfB, cna
S386 Dog Eye swab t2029 dt11c III 17 ST239 CC239 β-Lactams, CIP, TET,ERY, CLI (inducible)
mecA, ant(6′)-Ia, erm(C),
tet(K), tet(M) sea
sak, sea,
scn, hlb fnbA, clfA, clfB, cna, icaA
S400 Human Wound swab t4789 dr11c NT 22 ne CC239 β-Lactams, CIP, GEN,ERY, CLI
mecA, aacA-aphD,
ant(6′)-Ia, erm(C), tet(M) sea, sei
sak, sep,
scn, hlb fnbA, clfA, clfB, cna, icaA
S402 Human Wound swab t4789 dr11c III 22 ST239 CC239 β-Lactams, CIP, GEN,ERY, CLI
mecA, aacA-aphD,
ant(6′)-Ia, erm(C), tet(M) sea
sak, sep,
scn fnbA, clfA, clfB, cna, icaA
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Table 1. Cont.
Antimicrobial Resistance Virulence
FactorsID Host Clinical Site spa dru SCCmec MLVA * ST CC Phenotype ** Genes Detected IEC *** Miscellaneous Genes ****
S403 Human Wound swab t4789 dr11c III 23 ST239 CC239 β-Lactams, CIP, GEN mecA, aacA-aphD,ant(6′)-Ia, tet(M) sea
sak, sep,
scn, hlb fnbA, clfA, clfB, cna, icaA
S480 Human Wound swab t4789 dt11c NT 22 ne CC239 β-Lactams, CIP, GEN,ERY, CLI
mecA, aacA-aphD,
ant(6′)-Ia, erm(C), tet(M) sea
sak, scn,
hlb clfB, cna
S479 Human Wound swab t487 dt11c III 25 ST239 CC239 β-Lactams, CIP, GEN,ERY, CLI
mecA, aacA-aphD,
ant(6′)-Ia, erm(C), tet(M) sea
sak, sea,
scn, hlb fnbA, clfB, cna
S244a Human Wound swab t685 dt10a NT 26 ST938 CC30 β-Lactams, ERY, CLI mecA, ant(6
′)-Ia, erm(A),
erm(B) seg, sei, tsst-1
sak, scn,
hlb fnbA, clfA, clfB, icaA
S244b Human Wound swab t685 dt10a IV 27 ST938 CC30 β-Lactams, ERY, CLI mecA, erm(A), erm(B) seg, sei, tsst-1 sak, scn,hlb fnbA, clfA, clfB, icaA
S398 Dog Skin swab t487 dt10g NT 24 ST45 CC45 β-Lactams mecA, ant(6′)-Ia seg, sei chp, sak,scn fnbA, clfA, clfB, icaA
S395 Human Wound swab nt nt NT 1 ST111 CC5 β-Lactams, CIP, GEN,ERY, CLI, RIF
mecA, aacA-aphD,
ant(6’)-la, erm(A), erm(B) sea
sak, scn,
hlb fnbA, clfB, icaA
S258 Human Wound swab t041 dt8h I 13 ST111 CC5 β-Lactams, CIP, GEN,ERY, CLI
mecA, aacA-aphD,
ant(6′)-Ia, erm(A),
erm(B), tet(M)
sea, seg, sei sak, sea,scn, hlb fnbA, clfB, icaA
S396 Human Nose swab t12886 dt10a IV 16 ST5 CC5 β-Lactams, ERY, CLI(inducible) erm(A), erm(B)
sea, sed, seg,
sei
chp, sak,
scn, hlb fnbA, clfA, clfB, icaA
MRS1 Dog Wound swab t242 dt10a NT 19 CC5 β-Lactams, GEN aacA-aphD seg, sei
chp, sak,
sea, scn,
hlb
fnbA, clfA, clfB, icaA
MRS2 Dog Wound swab t242 dt10a NT 19 ST5 CC5 β-Lactams, GEN aacA-aphD seg, sei chp, sak,scn, hlb fnbA, clfA, clfB, icaA
MRS3 Dog Ear swab t242 dt10a V 20 ST5 CC5 β-Lactams aacA-aphD seg, sei chp, sak,scn, hlb fnbA, clfB
S422 Human Ear swab t024 dt7f IV 2 ST8 CC8 β-Lactams, GEN, ERY,CLI (inducible)
aacA-aphD, ant(6′)-Ia,
erm(C) sej
sak, scn,
hlb fnbA, clfA, clfB
S423 Human Nose swab t044 dt10 IV 14 ST80 CC80 β-Lactams, TET aacA-aphD, ant(6
′)-Ia,
tet(K) PVL
sak, scn,
hlb fnbA, clfA, clfB, icaA
S256 Human Wound swab t030 dt8a III +SCCmercury 3 ST444 _
β-Lactams, CIP, GEN,
TET, ERY, CLI, RIF
aacA-aphD, ant(6′)-Ia,
erm(A), erm(B), erm(C),
tet(M)
sea sak, sea,scn, hlb
fnbA, clfA, clfB, cna, icaA,
qacAB
S195 Human Skin swab t030 dt8a III 4 ST444 _
β-Lactams, CIP, GEN,
TET, CHL, ERY, CLI,
SXT
aacA-aphD, erm(A),
erm(B), erm(C), tet(M),
catpC221
sea sak, sea,scn, hlb fnbA, clfA, clfB, cna, icaA
S394 Human Wound swab t4272 dt10q NT 21 ST5907 _ β-Lactams, GEN, ERY,CLI aacA-aphD, erm(C) _
sak, sea,
scn, hlb fnbA, clfA, clfB, icaA, arsA
* Multiple locus variable number of tandem repeat analyses (MLVA) cluster. ** CIP = ciprofloxacin; GEN = gentamicin; TET = tetracycline; CHL = chloramphenicol; ERY = erythromycin;
CLI = clindamycin; RIF = rifampin; SXT = trimethoprim–sulfamethoxazole, ST = sequence type. *** Immune evasion complex (IEC) genes. **** Microbial surface components recognizing
adhesive matrix molecule (MSCRAMM) genes; biofilm formation gene; metal resistance genes; quaternary ammonium compound (QAC) resistance genes.
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One human and two animal MRSA isolates were only resistant to tested β-lactam antibiotics.
Multidrug resistance [19] was observed in 28 isolates originating from humans and in two isolates
from animals.
The presence of following antibiotic resistance genes was not detected in any of the tested MRSA
isolates: dfrA, dfrD, dfrG, dfrK; msrA; tet(L), tet(O); str; vat(A), vat(B), vat(C); cfr; catpC194, and catpC223
(Table 1).
2.2. Molecular Characterization
SCCmec typing of MRSA isolates of human origin revealed the presence of SCCmec type III as the
most frequent (n = 16), including three isolates with SCCmec type III + SCCmercury, SCCmec type IV
(n = 5), and I (n = 1). Eight MRSA isolates of human origin harbored nontypeable SCCmec. Two MRSA
isolates of animal origin carried SCCmec type III and V, while in four MRSA isolates, nontypeable
SCCmec elements were found (Table 1).
Among MRSA isolates originating from humans, it was determined that the predominant spa
type was t037 (n = 10), followed by t4789 (n = 4), t030 (n = 2), t041 (n = 2), t685 (n = 2), and single tones
t024, t038, t039, t040, t044, t223, t487, t1288, and t4272. For one isolate, the protein A variable region
could not be amplified by PCR. The predominant spa type among MRSA isolates originating from
companion animals was t242 (n = 3), followed by single tones t127, t487, and t2029 (Table 1).
The majority of human MRSA isolates derived at the same time from the hospital revealed a
uniform dru type—dt11c (n = 18). In addition to this predominant dru type among human isolates, the
presence of several dru types was detected: dt10a (n = 4), dt8a (n = 2), and single tones dt8h, dt10q,
dt7f, and dt10, while the dru type could not be determined for two isolates. The dru typing of animal
MRSA isolates identified four dru types: dt10a (n = 3) and single tones dt7o, dt10g, and dt11c (Table 1).
The MRSA strains exhibited 27 different multiple locus variable number of tandem repeat analyses
(MLVA) types (Table 1).
Among selected MRSAs, twelve sequence types (STs) could be detected (ST1, ST111, ST152, ST22,
ST239, ST444, ST45, ST5, ST8, ST80, ST938, and the new one ST5907 with new pta allele number 626,
with ST239 being predominant (n = 11) (Table 1).
The presence of three MRSA isolates with the same characteristics of the III-t037–dt11c–MLVA
cluster 8-ST239 were detected in human specimens, while two MRSA isolates with the
NT-t242-dt10a–MLVA cluster 19-ST5 were revealed from dog specimens (Table 1).
The following staphylococcal enterotoxin (SE) genes were detected in MRSA isolates of human
origin, sea in 23, seg in five, sei in eight, and sej in one isolate.
MRSA isolates of animal origin harbored sea (n = 1), seg (n = 4), seh (n = 1), and sei (n = 4).
Staphylococcal enterotoxin (SE) genes seb, sec, and see, and exfoliative toxin (ET) genes eta and etb
were not detected in any of the human and animal isolates.
PVL genes were found in two and the tsst-1 gene was found in three MRSA isolates originating
from humans. None of the animal isolates harbored PVL and tsst-1 genes (Table 1).
All examined immune evasion complex (IEC) genes were detected in MRSA isolates of human
origin: chp in two, sak in all 30, sea in 16, sep in five, scn in all 30, and hlb in 29 isoaltes. The following
IEC genes were identified in MRSA isolates of animal origin, sea in three, chp in four, hlb in five, and sak
and scn in all six isolates (Table 1). All tested adhesine genes were found in both human and animal
MRSA isolates, respectively: fnbA in 29 and in all six, clfA in 20 and in five, clfB in all 36, and cna in 20
and in one isolate. Gene that mediates biofilm formation icaA was detected in 21 human isolates and
in five animal isolates.
Metal resistance genes cadD, copB, and czrC, and QACs resistance gene smr were not detected in
the examined human and animal MRSA isolates. One human MRSA isolate carried the arsA gene and
one the qacAB gene.
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3. Discussion
S. aureus is frequently isolated from specimens of human origin, considering the fact that 30% of
the human population is colonized by S. aureus [20]. The MRSA finding in companion animals raises
questions about its origin. Cats and dogs are in close contact with humans, as companion animals are
often kept inside the house rather than outside [21]. This brings benefits for both sides but also risks
due to transmission of pathogens [1,22,23]. On the other hand, although MRSA strains causing serious
infections in dogs and cats are rarely isolated, they represent a clinical and therapeutic challenge [23].
However, zooantrophogenic transmission of MRSA has also been documented [24,25].
Results of susceptibility testing were in concordance with previously published results from Serbia
with an exception of resistance to trimethoprim–sulfamethoxazole, which has not been observed in the
past [13]. Generally, MRSA infections are caused by strains belonging to a several clonal complexes
where CC5, CC22, and CC45 are prevalent lineages in hospitals, while CC1 and CC80 are often isolated
in the community. CC8 and CC30 are pandemic and found in both hospitals and the community [26].
The prevalent spa type in human MRSA isolates was t037, which was previously reported in
Australia, Africa as the most prevalent and Asia as the second most prevalent type. In Europe, this has
been most the prevalent type in SCCmec III harboring strains [27]. In this study, this type was found in
ten MRSA isolates, of which seven contained SCCmec III (including two isolates with SCC mercury)
and three had nontypeable SCCmec elements. This t037-(SCCmec) III has different names, including
the Brazilian, Hungarian, and Vienna clone [28]. Among ST239 spa types, the most common was t037,
suggesting that this spa type represents the ancestral ST239 spa type [29]. ST239–MRSA-III is considered
to be the oldest pandemic MRSA strain, and has been circulating in Eastern Europe, but nowadays, in
most European countries, it has been replaced by other STs [8,30]. ST239 was observed in the recent
study from Serbia, and it was concluded that 34 HA-MRSA isolates collected in the period of three
years belonged to the single ’Serbian clade’ closely related to the Turkish clade [13]. One t037-SCCmec
nontypable PVL-positive MRSA isolate belonged to ST152. This ST was previously described in
patients tied with Macedonia and Kosovo [8] and in Serbia with a similar resistance pattern, different
spa types, and SCCmec type V [16]. It has been hypothesized that the PVL-positive ST152 MRSA cluster
in Central Europe originated from sub-Saharan Africa [31]. Further, isolate ST80–t044-IV possessed
PVL genes. The presence of ST80–t044-IV, PVL-positive strains was previously described in a healthcare
worker from Belgrade hospital and from an outpatient in Kragujevac, Serbia [14,16]. Additionally, this
spa type was previously found in CA-MRSA isolates belonging to CC80 (t044, SCCmec IV, and dt10a)
from Denmark, which were linked to Serbia [32]. The presence of two MRSA isolates t041 ST111-I and
ST239-III was detected in this study, while the presence of this spa type and CC5–MRSA-I was observed
in isolates from Serbia as well as Croatia [14,33]. In human MRSA isolates, two ST444–t030-III were
found. The spa type t030 was previously reported in Serbia in hospitalized patients and healthcare
workers [14,34].
One of our MRSA isolates was ST8–t024-IV. ST8-IV belongs to CA-MRSA, and it has been
commonly found in Europe [35].
During the present study, one isolate was spa type t039 and belonged to ST239-III. MRSA carrying
the same SCCmec element and belonged to the same spa type was isolated from a patient with
osteomyelitis in Germany, but in that study, isolates were not analyzed by multilocus sequence
typing (MLST) [36]. The two human isolates were ST938–t685, one harbored SCCmec IV, and
another nontypeable SCCmec, and both were tsst-1 positive. ST938 belongs to the CC30 clade, and
t685 was recorded in Germany and the Netherlands and associated with CC30 [37,38] In MRSA
isolate ST22–t223-IV, the tsst-1 gene was found. This strain was susceptible to all antibiotics except
beta-lactams, which has already been observed in MRSA belonged to the same spa and SCCmec type
from Sicily, the Gaza Strip, Jordan, and Kuwait and belonged to ST22 [39,40].
In animal MRSA isolates, ST5–t242 was predominant. In two isolates, SCCmec was nontypeable,
and in one, the SCCmec was type V. MRSA isolates belonging to spa type t242 and harboring SCCmec V
were previously described in healthcare workers in Serbia (CC5–MRSA-V–t242) [14]. A multiresistant
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MRSA ST1 isolate originating from a cat with nontypeable SCCmec element belonged to t127, which
was previously detected in SCCmec IV-harboring strains from Europe and in strains carrying SCCmec I
and IV from America [27]. This spa type has been associated with ST1–MRSA–SCCmec Iva, which is
one of the most common CA-MRSA strains in the UK, but it also was found in pigs, except that SCCmec
was type V [41]. The spa type t2029 was detected in ST239–MRSA-III and was multidrug-resistant.
This spa type was previously described in MRSA isolated from a patient in Cuba [42].
Direct repeat unit (dru) typing has never been applied in epidemiological analysis of MRSA
isolates from Serbia. The dominant dru type among human MRSA isolates was dt11c. This type was
found in 14 isolates carrying SCCmec III (t037, t038, t039, t040, t041, t487, and t4789) and in four isolates
carrying nontypeable SCCmec elements (t037, t4789). Further, this dru type was found in an animal
MRSA isolate belonging to t2029 harboring SCCmec III. This dru type was previously reported in
MRSA belonging to CC398-V–t011 isolated from a slaughterhouse worker in Germany [43] but also as
the most prevalent dru type in methicillin-resistant and multidrug-resistant strains of Staphylococcus
capitis isolated from neonates in an intensive-care unit in France, Belgium, the United Kingdom, and
Australia [44]. The second most prevalent dru type in human isolates was dt10a, which was the
most prevalent dru type in animal isolates. In our study, this dru type was found in human MRSA
isolates harboring SCCmec type IV (ST938–t685, ST5–t12886) and nontypeable SCCmec (ST152–t037,
ST938–t685), and in animal MRSA isolates that carried SCCmec type V and nontypeable SCCmec
(ST5–t242). The dru type dt10a is a widespread type that has previously been associated with diverse
MRSA strains harboring different SCCmec elements and belonging to various clones [45]. The European
CA-MRSA ST80–MRSA-IV strain appears to be conserved with respect to dt10a, and this type is the
major dru type in Scottish EMRSA-15 and Denmark CC80–MRSA-IV strains [32,46]. Moreover, this dru
type was found in both human and chicken isolates belonging to ST9 (SCCmec IV and t1430) [43]. Both
dru types dt10a (SCCmec type IV) and dt11c (SCCmec type III) were found in MRSA strains belonging
to ST239–t037 isolated from hospitalized patients in Malaysia [47]. The dru type dt8a was identified in
two human MRSA isolates ST444–t030-III. This dru type, together with dt10a was previously detected
among ST239–MRSA-III and ST22–MRSA-IV isolates [48]. In one human MRSA isolate, dru type
dt8h was detected. This isolate belonging to ST111–t041 was the only one harboring SCCmec type I.
The dru type dt8h was found in an MRSA strain isolated from a cat in Australia, and it belonged to
ST22–MRSA-IV, t379 [49]. One of the human MRSA isolates—ST5907–t4272—exhibited dru type dt10q
with nontypeable SCCmec element. This dru type was previously reported in ST398–MRSA-IV, t011 of
bovine origin and chickens [43,50]. One of the human MRSA isolates—ST8–t024-IV—belonged to dru
type dt7f. This dru type was previously described in ST239–MRSA-III, t030 isolated from a patient in
Romania [51].
One animal MRSA isolate—ST45–t487—carried nontypeable SCCmec and exhibited dru type
dt10g. This dru type was previously reported in different Scottish hospitals as well as in Romanian
hospitals [46,52]. In one of the animal MRSA isolates, with ST1–t127 belonging to dru type
dt7o, the SCCmec element was nontypeable. This dru type was previously described in CC1 and
CC80–MRSA-IV–t127 isolated from patients in a Romanian hospital [51].
It was reported that every CC lineage had a typical collection of enterotoxin genes, for example,
sed-sej-ser located on pathogenicity islands in CC45, while sed-sej-ser found on plasmid were usually
detected in CC8. Further, prophage-borne sea was sporadically identified in CC8, CC30, CC45, and
CC395. Common HA-MRSA and CA-MRSA lineages carry enterotoxin genes specific to a particular
lineage [53]. According to previous reports, SEA has been the most prevalent of all SEs [54], which is
in accordance with results of this study. In addition to sea, sei, and seg were detected as the second and
third most prevalent SEs genes in humans, respectively, and the most prevalent in isolates from dogs.
It has been suggested that human S. aureus isolates harbor the operon egc containing seg and sei [55],
but both genes were found in S. aureus isolated from dogs in Portugal [56].
The IEC genes encode proteins which have specific interaction with human immune response:
chp (chemotaxis inhibitory protein), sak (staphylokinase), particular enterotoxin genes as sea, sep
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and sek, scn (staphylococcal complement inhibitor), and hlb (haemolysin-β). These genes (human
adaptation-related genes) are used as a marker of human origin [57]. The sak and scn genes were found
in all 36 isolates, suggesting that all isolates could have human origin.
4. Materials and Methods
4.1. Isolates
In total, 36 nonrepetitive MRSA isolates from humans (n = 30) and companion animals (n = 6, 5
canine, and 1 feline) were included in this study. Human isolates were obtained from different clinical
specimens (sputum, wound, nose, ear, and skin swabs) of outpatients and inpatients hospitalized at
the Military Medical Academy in Belgrade, Serbia during six months in 2016. In the same period,
animal isolates were collected from swabs (wound, skin, eye, and ear) during routine diagnostics at
the Department of Microbiology of the Faculty of Veterinary Medicine at the University of Belgrade.
The study was conducted in accordance with the Declaration of Helsinki, and the research was
approved by the Ethics Committee of the Military Medical Academy in Belgrade, Serbia. Examination
of the animal samples was carried out as part of the routine bacteriological diagnostic activities at the
Department of Microbiology at the Faculty of Veterinary Medicine, University of Belgrade. Therefore,
according to the Good Scientific Practice of the Faculty of Veterinary Medicine at the University of
Belgrade, these clinical examinations were not subject to the Faculty of Veterinary Medicine Ethics and
Animal Welfare Commission reporting obligations.
4.2. Identification of Methicillin-Resistant Staphylococcus aureus
Samples were inoculated on Columbia agar with 5% sheep blood (bioMérieux, Marcy-l’ Etoile,
France). Colonies resembling Staphylococcus aureus were subjected to further investigation. Isolates
were identified according to standard bacteriological protocols and confirmed using matrix-assisted
laser desorption/ionization–time of flight spectrometry (MALDI-TOF, Bruker, Germany). Cefoxitin
resistance was confirmed by agar disk diffusion as well as by PCRs for mecA and mecC [58,59].
4.3. Antibiotic Susceptibility Testing
Antibiotic susceptibility testing of S. aureus isolates was performed using agar disk diffusion
on Mueller Hinton II Agar (Becton Dickinson, USA) according to Clinical and Laboratory Standards
Institute (CLSI) standard [58]. The following antibiotics were tested; penicillin (10 U), cefoxitin
(30 µg), erythromycin (15 µg), clindamycin (2 µg), chloramphenicol (30 µg), gentamicin (10 µg),
amikacin (30 µg), trimethoprim–sulfamethoxazole (1.25/23.75 µg), tetracycline (30 µg), ciprofloxacin
(5 µg), teicoplanin (30 µg), rifampin (5 µg), and linezolid (30 µg) (Becton Dickinson, USA). PCR
was conducted for revealing the presence of the following antibiotic resistance genes: erm(A),
erm(B), and erm(C) (confer resistance to macrolides, lincosamides, and streptogramin B); msrA
(confers resistance to macrolides and streptogramin B); vat(A), vat(B), and vat(C) (confer resistance to
streptogramin A); cfr (confers resistance to all phenicols, lincosamides, oxazolidinones, pleuromutilins,
and streptogramin A); fexA (confers resistance to all phenicols); catpC194, catpC221, and catpC223
(confer resistance to nonfluorinated phenicols–chloramphenicol); aac-aphD (confers resistance to
aminoglycosides–gentamicin, kanamycin, tobramycin, and, when overexpressed, to amikacin);
ant(6′)-Ia and str (confer resistance to aminoglycoside–streptomycin); dfrA, dfrD, dfrG, and dfrK (confer
resistance to trimethoprim); tet(K) and tet(L) (confers resistance to tetracyclines except minocycline
and glycylcyclines); tet(M) (confers resistance to tetracyclines, including minocycline but excluding
glycylcyclines); and tet(O) [60–69].
4.4. Genotyping of MRSA
All strains were further genotyped by SCCmec, spa typing, and dru typing, by multiple locus
variable number of tandem repeat analyses (MLVA) and by multilocus sequence typing (MLST) [69] of
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selected isolates (each representing a distinct MLVA cluster). Allele and sequence type number were
assigned and used for goeBURST analysis using PHYLOViZ [70] (Figure 1).
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of 27 MRSA isolates. An eBURST diagram was calculated using PHYLOViZ with the goeBURST
algorithm. STs were grouped according to their allelic profiles.
4.5. Detection of Virulence and Other Determinants
The detection of Panton–Valentine leukocidin (PVL) genes (lukS-PV and lukF-PV) as well as
staphylococcal enterotoxin (SE) genes (sea, seb, sec, sed, see, seg, seh, sei, and sej) and the toxic shock
syndrome toxin (TSST) gene (tsst-1) was as previously described [67].
Exfoliative toxin (ET) genes eta and etb were determined by the PCR protocol previously
described [71].
The presence of immune evasion complex (IEC) genes—chemotaxis inhibitory protein gene (chp),
staphylokinase gene (sak), staphylococcal enterotoxin A gene (sea), staphylococcal enterotoxin P gene
(sep), staphylococcal complement inhibitor gene (scn), and haemolysin-β gene (hlb)—was confirmed
by the PCR protocol previously described [72].
Microbial surface components recognizing adhesive matrix molecule (MSCRAMMs) genes: fnbA
(fibronecting binding protein A), clfA and clfB, (clumping factors A and B), and cna (collagen binding
protein) were targeted using the PCR protocol previously described [73].
The presence of the icaA gene that mediates biofilm formation was determined by the PCR
protocol previously described [73].
Metal resistance genes arsA (arsenic compounds), cadD (cadmium), copB (copper), and czrC
(zinc/cadmium) genes, as well as genes for quaternary ammonium compound (QACs) resistance
(qacAB and smr) were carried out using PCR as previously described [68].
5. Conclusions
This study provided insight into the characteristics of MRSA strains collected from patients
in one hospital in Belgrade, as well as from dogs and cat at a certain point f time. Further, thi
is the first report on MRSA isolates originatin from dogs and cat in Serbia. Th presence of ST5,
ST45, and ST239 MRSA strains was revealed in specimens originating from companion animals.
This discovery indicated that MRSA strains moved f om hospitals not only to the co munity and the
general population, but also to companion animals. This fact could point ut that, to some de ree,
companion a imals might be reservoirs of HA-MRSA strains.
Author Contributions: Conceptualization, J.A., D.M., and I.L.; Methodology, J.A., D.M., K.A., Z.T., B.R., I.K., J.S.,
and I.L.; Validation, J.A., D.M., J.S., and I.L.; Formal Analysis and Investigation, J.A., D.M., K.A., Z.T., B.R., I.K.,
and I.L.; Writing—Original Draft Preparation, J.A.; Writing—Review and Editing, J.S. and I.L.
Antibiotics 2019, 8, 26 10 of 14
Funding: This study was partially supported by the Ministry of Education, Science and Technological
Development of the Republic of Serbia, Project No. TR31079, http://www.mpn.gov.rs/. The funder had no role
in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Acknowledgments: We are grateful to MDPI’s professional English editing service for improving our
English style.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Morgan, M. Methicillin-resistant Staphylococcus aureus and animals: Zoonosis or humanosis? J. Antimicrob.
Chemother. 2008, 62, 1181–1187. [CrossRef] [PubMed]
2. International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements
(IWG-SCC). Classification of Staphylococcal Cassette Chromosome mec (SCCmec): Guidelines for Reporting
Novel SCCmec Elements. Antimicrob. Agents Chemother. 2009, 53, 4961–4967. [CrossRef] [PubMed]
3. Monecke, S.; Slickers, P.; Gawlik, D.; Müller, E.; Reissig, A.; Ruppelt-Lorz, A.; de Jäckel, S.C.; Feßler, A.T.;
Frank, M.; Hotzel, H.; Kadlec, K.; et al. Variability of SCCmec elements in livestock-associated CC398 MRSA.
Vet. Microbiol. 2018, 217, 36–46. [CrossRef] [PubMed]
4. Baig, S.; Johannesen, T.B.; Overballe-Petersen, S.; Larsen, J.; Larsen, A.R.; Stegger, M. Novel SCCmec type
XIII (9A) identified in an ST152 methicillin-resistant Staphylococcus aureus. Infect. Genet. Evol. 2018, 61, 74–76.
[CrossRef]
5. Lakhundi, S.; Zhang, K. Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution,
and Epidemiology. Clin. Microbiol. Rev. 2018, 31, e00020-18. [CrossRef]
6. Köck, R.; Becker, K.; Cookson, B.; van Gemert-Pijnen, J.E.; Harbarth, S.; Kluytmans, J.; Mielke, M.; Peters, G.;
Skov, R.L.; Struelens, M.J.; et al. Methicillin-resistant Staphylococcus aureus (MRSA): Burden of disease and
control challenges in Europe. Eur. Surveill. 2010, 15, 19688. [CrossRef]
7. Malachowa, N.; DeLeo, F. Mobile genetic elements of Staphylococcus aureus. Cell. Mol. Life Sci. 2010, 67,
3057–3071. [CrossRef] [PubMed]
8. Monecke, S.; Coombs, G.; Shore, A.C.; Coleman, D.C.; Akpaka, P.; Borg, M.; Chow, H.; Ip, M.; Jatzwauk, L.;
Jonas, D.; et al. A Field Guide to Pandemic, Epidemic and Sporadic Clones of Methicillin-Resistant
Staphylococcus aureus. PLoS ONE 2011, 6, e17936. [CrossRef]
9. McDougal, L.K.; Fosheim, G.E.; Nicholson, A.; Bulens, S.N.; Limbago, B.M.; Shearer, J.E.S.; Summers, A.O.;
Patel, J.B. Emergence of Resistance among USA300 Methicillin-Resistant Staphylococcus aureus Isolates
Causing Invasive Disease in the United States. Antimicrob. Agents Chemother. 2010, 54, 3804–3811. [CrossRef]
10. Uhlemann, A.C.; Otto, M.; Lowy, F.D.; DeLeo, F.R. Evolution of community- and healthcare-associated
methicillin-resistant Staphylococcus aureus. Infect. Genet. Evol. 2013, 21, 563–574. [CrossRef]
11. Morris, D.O.; Loeffler, A.; Davis, M.F.; Guardabassi, L.; Weese, J.S. Recommendations for approaches to
meticillin-resistant staphylococcal infections of small animals: Diagnosis, therapeutic considerations and
preventative measures. Clinical Consensus Guidelines of the World Association for Veterinary Dermatology.
Vet. Dermatol. 2017, 28, 304.e69. [CrossRef]
12. De Backer, S.; Xavier, B.B.; Vanjari, L.; Coppens, J.; Lammens, C.; Vemu, L.; Carevic, B.; Hryniewicz, W.;
Jorens, P.; Kumar-Singh, S.; et al. Remarkable geographical variations between India and Europe in carriage of
the staphylococcal surface protein-encoding sasX/sesI and in the population structure of methicillin-resistant
Staphylococcus aureus belonging to clonal complex 8. Clin. Microbiol. Infect. 2018. [CrossRef]
13. Cirkovic, I.; Stepanovic, S.; Skov, R.; Trajkovic, J.; Grgurevic, A.; Larsen, A.R. Carriage and genetic diversity
of methicillin-resistant Staphylococcus aureus among patients and healthcare workers in a Serbian University
Hospital. PLoS ONE 2015, 10, e0127347. [CrossRef]
14. Cirkovic, I.; Djukic, S.; Carevic, B.; Mazic, N.; Mioljevic, V.; Stepanovic, S. Methicillin-resistant Staphylococcus
aureus nasal carriage among hospitalized patients and healthcare workers in the Clinical Centre of Serbia.
Arch. Biol Sci. 2014, 66, 87–92. [CrossRef]
15. Cirkovic, I.; Sørum, M.; Radenkovic, D.; Vlahovic, M.S.; Larsen, A.R. National surveillance reveals findings
of Panton-Valentine leukocidin positive meticillin-resistant Staphylococcus aureus in Serbia. J. Med. Microbiol.
2013, 62, 342–344. [CrossRef]
Antibiotics 2019, 8, 26 11 of 14
16. Zutic, M.; Cirkovic, I.; Pavlovic, Lj.; Zutic, J.; Asanin, J.; Radanovic, O.; Pavlovic, N. Occurrence of
methicillin-resistant Staphylococcus aureus in milk samples from Serbian cows with subclinical mastitis.
Afr. J. Microbiol. Res. 2012, 6, 5887–5889. [CrossRef]
17. Zutic, M.; Cirkovic, I.; Pavlovic, Lj.; Asanin, J.; Jovanovic, S.; Zutic, J.; Asanin, R. First isolation of
methicillin-resistant Staphylococcus aureus from pigs’clinical samples in Serbia. Acta Vet. Brno. 2012, 81,
225–227. [CrossRef]
18. Velebit, B.; Fetsch, A.; Mirilovic, M.; Teodorovic, V.; Jovanovic, M. MRSA in pigs in Serbia. Vet. Rec. 2010,
167, 183–184. [CrossRef]
19. Sweeney, M.; Lubbers, B.; Schwarz, S.; Watts, J. Applying definitions for multidrug resistance extensive
drug resistance and pandrug resistance to clinically significant livestock and companion animal bacterial
pathogens. J. Antimicrob. Chemother. 2018, 73, 1460–1463. [CrossRef]
20. Van Belkum, A.; Melles, D.C.; Nouwen, J.; van Leeuwen, W.B.; van Wamel, W.; Vos, M.C.; Wertheim, H.F.L.;
Verbrugh, H.A. Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect.
Genet. Evol. 2009, 9, 32–47. [CrossRef]
21. Bierowiec, K.; Płoneczka-Janeczko, K.; Rypuła, K. Is the Colonisation of Staphylococcus aureus in Pets
Associated with Their Close Contact with Owners? PLoS ONE 2016, 11, e0156052. [CrossRef]
22. Guardabassi, L.; Larsen, J.; Weese, J.S.; Butaye, P.; Battisti, A.; Kluytmans, J.; Lloyd, D.H.; Skov, R.L. Public
health impact and antimicrobial selection of meticillin-resistant staphylococci in animals. J. Glob. Antimicrob.
Resist. 2013, 1, 55–62. [CrossRef]
23. Guardabassi, L.; Schwarz, S.; Lloyd, D.H. Pet animals as reservoirs of antimicrobial-resistant bacteria: Review.
J. Antimicrob. Chemother. 2004, 54, 321–332. [CrossRef]
24. Loncaric, I.; Brunthaler, R.; Spergser, J. Suspected goat-to-human transmission of methicillin-resistant
Staphylococcus aureus sequence type 398. J. Clin. Microbiol. 2013, 51, 1625–1626. [CrossRef]
25. Loncaric, I.; Künzel, F.; Klang, A.; Wagner, R.; Licka, T.; Grunert, T.; Feßler, A.T.; Geier-Dömling, D.;
Rosengarten, R.; Müller, E.; et al. Carriage of meticillin-resistant staphylococci between humans and animals
on a small farm. Vet. Dermatol. 2016, 27, 191-e48. [CrossRef]
26. Baldan, R.; Rancoita, P.M.V.; Di Serio, C.; Mazzotti, M.; Cichero, P.; Ossi, C.; Biancardi, A.; Nizzero, P.;
Saracco, A.; Scarpellini, P.; et al. Epidemic MRSA clone ST22-IV is more resistant to multiple host- and
environment-related stresses compared with ST228-I. J. Antimicrob. Chemother. 2015, 70, 757–765. [CrossRef]
27. Asadollahi, P.; Farahani, N.N.; Mirzaii, M.; Khoramrooz, S.S.; van Belkum, A.; Asadollahi, K.;
Dadashi, M.; Darban-Sarokhalil, D. Distribution of the Most Prevalent Spa Types among Clinical Isolates of
Methicillin-Resistant and –Susceptible Staphylococcus aureus around the World: A Review. Front. Microbiol.
2018, 9, 163. [CrossRef]
28. Smyth, D.S.; McDougal, L.K.; Gran, F.W.; Manoharan, A.; Enright, M.C.; Song, J.-H.; de Lencastre, H.;
Robinson, D.A. Population Structure of a Hybrid Clonal Group of Methicillin-Resistant Staphylococcus aureus,
ST239-MRSA-III. PLoS ONE 2010, 5, e8582. [CrossRef]
29. Harris, S.R.; Feil, E.J.; Holden, M.T.G.; Quail, M.A.; Nickerson, E.K.; Chantratita, N.; Gardete, S.; Tavares, A.;
Day, N.; Lindsay, J.A.; et al. Evolution of MRSA during hospital transmission and intercontinental spread.
Science 2010, 327, 469–474. [CrossRef]
30. Monecke, S.; Slickers, P.; Gawlik, D.; Müller, E.; Reissig, A.; Ruppelt-Lorz, A.; Akpaka, P.E.; Bandt, D.;
Bes, M.; Boswihi, S.S.; et al. Molecular Typing of ST239-MRSA-III from Diverse Geographic Locations and
the Evolution of the SCCmec III Element during Its Intercontinental Spread. Front. Microbiol. 2018, 9, 1436.
[CrossRef]
31. Stegger, M.; Wirth, T.; Andersen, P.S.; Skov, R.L.; De Grassi, A.; Simões, P.M.; Tristan, A.; Petersen, A.; Aziz, M.;
Kiil, K.; et al. Origin and evolution of European community-acquired methicillin-resistant Staphylococcus
aureus. MBio 2014, 5, e01044-14. [CrossRef]
32. Larsen, A.R.; Böcher, S.; Stegger, M.; Goering, R.; Pallesen, L.V.; Skov, R. Epidemiology of European
Community-Associated Methicillin-Resistant Staphylococcus aureus Clonal Complex 80 Type IV Strains
Isolated in Denmark from 1993 to 2004. J. Clin. Microbiol. 2008, 46, 62–68. [CrossRef]
33. Budimir, A.; Deurenberg, R.H.; Bosnjak, Z.; Stobberingh, E.E.; Cetkovic, H.; Kalenic, S. A variant of the
Southern German clone of methicillin-resistant Staphylococcus aureus is predominant in Croatia. Clin.
Microbiol. Infect. 2010, 16, 1077–1083. [CrossRef]
Antibiotics 2019, 8, 26 12 of 14
34. Petersson, A.C.; Olsson-Liljequist, B.; Miorner, H.; Hæggman, S. Evaluating the usefulness of spa typing,
in comparison with pulsed-field gel electrophoresis, for epidemiological typing of methicillin-resistant
Staphylococcus aureus in a low-prevalence region in Sweden 2000–2004. Clin. Microbiol. Infect. 2010, 16,
456–462. [CrossRef]
35. Strauß, L.; Stegger, M.; Akpaka, P.E.; Alabi, A.; Breurec, S.; Coombs, G.; Egyir, B.; Larsen, A.R.; Laurent, F.;
Monecke, S.; et al. Origin, evolution, and global transmission of community-acquired Staphylococcus aureus
ST8. PNAS 2017, 114, E10596–E10604. [CrossRef]
36. Garofalo, A.; Giai, C.; Lattar, S.; Gardella, N.; Mollerach, M.; Kahl, B.C.; Becker, K.; Prince, A.S.; Sordelli, D.O.;
Gómez, M.I. The Length of the Staphylococcus aureus Protein A Polymorphic Region Regulates Inflammation:
Impact on Acute and Chronic Infection. J. Infect. Dis. 2012, 206, 81–90. [CrossRef]
37. Rijnders, M.I.A.; Deurenberg, R.H.; Boumans, M.L.L.; Hoogkamp-Korstanje, J.A.A.; Beisser, P.S.;
Stobberingh, E.E. The Antibiotic Resistance Surveillance Group. Population Structure of Staphylococcus
aureus Strains Isolated from Intensive Care Unit Patients in The Netherlands over an 11-Year Period (1996 to
2006). J. Clin. Microbiol. 2009, 47, 4090–4095. [CrossRef]
38. Cuny, C.; Layer, F.; Werner, G.; Harmsen, D.; Daniels-Haardt, I.; Jurke, A.; Mellmann, A.; Witte, W.; Köck, R.
State-wide surveillance of antibiotic resistance patterns and spa types of methicillin-resistant Staphylococcus
aureus from blood cultures in North Rhine-Westphalia, 2011–2013. Clin. Microbiol. Infect. 2015, 21, 750–757.
[CrossRef]
39. Aqel, A.A.; Alzoubi, H.M.; Vickers, A.; Pichon, B.; Kearns, A.M. Molecular epidemiology of nasal isolates of
methicillin-resistant Staphylococcus aureus from Jordan. J. Infect. Public Health 2015, 8, 90–97. [CrossRef]
40. Udo, E.E.; Boswihi, S.S.; Al-Sweih, N. High prevalence of toxic shock syndrome toxin–producing epidemic
methicillin-resistant Staphylococcus aureus 15 (EMRSA-15) strains in Kuwait hospitals. New Microbes New
Infect. 2016, 12, 24–30. [CrossRef]
41. Franco, A.; Hasman, H.; Iurescia, M.; Lorenzetti, R.; Stegger, M.; Pantosti, A.; Feltrin, F.; Ianzano, A.;
Porrero, M.C.; Liapi, M.; et al. Molecular characterization of spa type t127, sequence type 1
methicillin-resistant Staphylococcus aureus from pigs. J. Antimicrob. Chemother. 2011, 66, 1231–1235. [CrossRef]
42. Hopman, J.; Peraza, G.T.; Espinosa, F.; Klaassen, C.; Velázquez, D.; Meis, J.; Voss, A. Methicillin-resistant
Staphylococcus aureus without borders: USA300 in Cuba. BMC Proc. 2011, 5 (Suppl. 6), 172. [CrossRef]
43. Wendlandt, S.; Kadlec, K.; Feßler, A.T.; Monecke, S.; Ehricht, R.; van de Giessen, A.W.; Hengeveld, P.D.;
Huijsdens, X.; Schwarz, S.; van Duijkeren, E. Resistance phenotypes and genotypes of methicillin-resistant
Staphylococcus aureus isolates from broiler chickens at slaughter and abattoir workers. J. Antimicrob. Chemother.
2013, 68, 2458–2463. [CrossRef]
44. Butin, M.; Rasigade, J.P.; Martins-Simões, P.; Meugnier, H.; Lemriss, H.; Goering, R.V.; Kearns, A.;
Deighton, M.A.; Denis, O.; Ibrahimi, A.; et al. Wide geographical dissemination of the multiresistant
Staphylococcus capitis NRCS-A clone in neonatal intensive-care units. Clin. Microbiol. Infect. 2016, 22, 46–52.
[CrossRef]
45. Bartels, M.D.; Boye, K.; Oliveira, D.C.; Worning, P.; Goering, R.; Westh, H. Associations between dru Types
and SCCmec Cassettes. PLoS ONE 2013, 8, e61860. [CrossRef]
46. Goering, R.V.; Morrison, D.; Al-Doori, Z.; Edwards, G.F.S.; Gemmell, C.G. Usefulness of mec-associated direct
repeat unit (dru) typing in the epidemiological analysis of highly clonal methicillin-resistant Staphylococcus
aureus in Scotland. Clin. Microbiol. Infect. 2008, 14, 964–969. [CrossRef]
47. Lim, K.T.; Yeo, C.C.; Suhaili, Z.; Thong, K.L. Comparison of Methicillin-Resistant and Methicillin-Sensitive
Staphylococcus aureus Strains Isolated from a Tertiary Hospital in Terengganu, Malaysia. Jpn. J. Infect. Dis.
2012, 65, 502–509. [CrossRef]
48. Shore, A.C.; Rossney, A.S.; Kinnevey, P.M.; Brennan, O.M.; Creamer, E.; Sherlock, O.; Dolan, A.; Cunney, R.;
Sullivan, D.J.; Goering, R.V.; et al. Enhanced Discrimination of Highly Clonal ST22-Methicillin-Resistant
Staphylococcus aureus IV Isolates Achieved by Combining spa, dru, and Pulsed-Field Gel Electrophoresis
Typing Data. J. Clin. Microbiol. 2010, 48, 1839–1852. [CrossRef]
49. Worthing, K.A.; Abraham, S.; Pang, S.; Coombs, G.W.; Saputra, S.; Jordan, D.; Wong, H.S.; Abraham, R.J.;
Trott, D.J.; Norris, J.M. Molecular Characterization of Methicillin-Resistant Staphylococcus aureus Isolated
from Australian Animals and Veterinarians. Microb. Drug. Resist. 2018, 24, 203–212. [CrossRef]
Antibiotics 2019, 8, 26 13 of 14
50. Feßler, A.; Scott, C.; Kadlec, K.; Ehricht, R.; Monecke, S.; Schwarz, S. Characterization of methicillin-resistant
Staphylococcus aureus ST398 from cases of bovine mastitis. J. Antimicrob. Chemother. 2010, 65, 619–625.
[CrossRef]
51. Ionescu, R.; Mediavilla, J.R.; Chen, L.; Grigorescu, D.O.; Idomir, M.; Kreiswirth, B.N.; Roberts, R.B. Molecular
Characterization and Antibiotic Susceptibility of Staphylococcus aureus from a Multidisciplinary Hospital in
Romania. Microb. Drug. Resist. 2010, 16, 263–272. [CrossRef]
52. Chen, L.; Mediavilla, J.R.; Smyth, D.S.; Chavda, K.D.; Ionescu, R.; Roberts, R.B.; Robinson, D.A.;
Kreiswirth, B.N. Identification of a Novel Transposon (Tn6072) and a Truncated Staphylococcal Cassette
Chromosome mec Element in Methicillin-Resistant Staphylococcus aureus ST239. Antimicrob. Agents Chemother.
2010, 54, 3347–3354. [CrossRef]
53. Strommenger, B.; Layer, F.; Werner, G. Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in
workers in the food industry. In Staphylococcus aureus, 1st ed.; Fetsch, A., Ed.; Academic Press: Cambridge,
MA, USA, 2018; pp. 163–188.
54. Hennekinne, J.A. Staphylococcus aureus as a leading cause of foodborne outbreaks worldwide. In
Staphylococcus aureus, 1st ed.; Fetsch, A., Ed.; Academic Press: Cambridge, MA, USA, 2018; pp. 129–146.
55. Smyth, D.S.; Hartigan, P.J.; Meaney, W.J.; Fitzgerald, J.R.; Deobald, C.F.; Bohach, G.A.; Smyth, C.J.
Superantigen genes encoded by the egc cluster and SaPIbov are predominant among Staphylococcus aureus
isolates from cows, goats, sheep, rabbits and poultry. J. Med. Microbiol. 2005, 54, 401–411. [CrossRef]
56. Couto, N.; Belas, A.; Kadlec, K.; Schwarz, S.; Pomba, C. Clonal diversity, virulence patterns and antimicrobial
and biocide susceptibility among human, animal and environmental MRSA in Portugal. J. Antimicrob.
Chemother. 2015, 70, 2483–2487. [CrossRef]
57. Zarazaga, M.; Gómez, P.; Ceballos, S.; Torres, C. Molecular epidemiology of Staphylococcus aureus lineages in
the animal-human interface. In Staphylococcus aureus, 1st ed.; Fetsch, A., Ed.; Academic Press: Cambridge,
MA, USA, 2018; pp. 189–214.
58. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 26th
ed.; CLSI supplement M100S; CLSI: Wayne, PA, USA, 2016; pp. 74–80.
59. Loncaric, I.; Kübber-Heiss, A.; Posautz, A.; Stalder, G.L.; Hoffmann, D.; Rosengarten, R.; Walzer, C.
Characterization of methicillin-resistant Staphylococcus spp. carrying the mecC gene, isolated from wildlife. J.
Antimicrob. Chemother. 2013, 68, 2222–2225. [CrossRef]
60. Aarestrup, F.M.; AgersŁ, Y.; Ahrens, P.; JŁrgensen, J.C.; Madsen, M.; Jensen, L.B. Antimicrobial susceptibility
and presence of resistance genes in staphylococci from poultry. Vet. Microbiol. 2000, 74, 353–364. [CrossRef]
61. Martineau, F.; Picard, F.J.; Lansac, N.; Ménard, C.; Roy, P.H.; Ouellette, M.; Bergeron, M.G. Correlation
between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility
patterns of Staphylococcus aureus and Staphylococcus Antimicrob. Agents Chemother. 2000, 44, 231–238.
[CrossRef]
62. Kehrenberg, C.; Schwarz, S. Distribution of florfenicol resistance genes fexA and cfr among
chloramphenicol-resistant Staphylococcus isolates. Antimicrob. Agents Chemother. 2006, 50, 1156–1163.
[CrossRef]
63. Schnellmann, C.; Gerber, V.; Rossano, A.; Jaquier, V.; Panchaud, Y.; Doherr, M.G.; Thomann, A.; Straub, R.;
Perreten, V. Presence of new mecA and mph(C) variants conferring antibiotic resistance in Staphylococcus spp.
isolated from the skin of horses before and after clinic admission. J. Clin. Microbiol. 2006, 44, 4444–4454.
[CrossRef]
64. Hauschild, T.; Vukovic, D.; Dakic´, I.; Ježek, P.; Djukic´, S.; Dimitrijevic´, V.; Stepanovic´, S.; Schwarz, S.
Aminoglycoside Resistance in Members of the Staphylococcus sciuri Group. Microb. Drug Resist. 2007, 13,
77–84. [CrossRef]
65. Argudín, M.A.; Tenhagen, B.A.; Fetsch, A.; Sachsenröder, J.; Käsbohrer, A.; Schroeter, A.; Hammerl, J.A.;
Hertwig, S.; Helmuth, R.; Bräunig, J.; et al. Virulence and resistance determinants of German Staphylococcus
aureus ST398 isolates from nonhuman sources. Appl. Environ. Microbiol. 2011, 77, 3052–3060. [CrossRef]
66. Shittu, A.O.; Okon, K.; Adesida, S.; Oyedara, O.; Witte, W.; Strommenger, B.; Layer, F.; Nübel, U. Antibiotic
resistance and molecular epidemiology of Staphylococcus aureus in Nigeria. BMC Microbiol. 2011, 11, 92.
[CrossRef]
Antibiotics 2019, 8, 26 14 of 14
67. Loncaric, I.; Künzel, F.; Licka, T.; Simhofer, H.; Spergser, J.; Rosengarten, R. Identification and characterization
of methicillin-resistant Staphylococcus aureus (MRSA) from Austrian companion animals and horses. Vet.
Microbiol. 2014, 168, 381–387. [CrossRef]
68. Schauer, B.; Krametter-Frötscher, R.; Knauer, F.; Ehricht, R.; Monecke, S.; Feßler, A.T.; Schwarz, S.; Grunert, T.;
Spergser, J.; Loncaric, I. Diversity of methicillin-resistant Staphylococcus aureus (MRSA) isolated from Austrian
ruminants and New World camelids. Vet. Microbiol. 2018, 215, 77–82. [CrossRef]
69. Feßler, A.T.; Li, J.; Kadlec, K.; Wang, Y.; Schwarz, S. Antimicrobial resistance properties of Staphylococcus
aureus. In Staphylococcus aureus, 1st ed.; Fetsch, A., Ed.; Academic Press: Cambridge, MA, USA, 2018;
pp. 57–85.
70. Francisco, A.P.; Vaz, C.; Monteiro, P.T.; Melo-Cristino, J.; Ramirez, M.; Carriço, J.A. PHYLOViZ: Phylogenetic
inference and data visualization for sequence based typing methods. BMC Bioinform. 2012, 13, 87. [CrossRef]
71. Mehrotra, M.; Wang, G.; Johnson, W.M. Multiplex PCR for detection of genes for Staphylococcus aureus
enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance. J. Clin. Microbiol.
2000, 38, 1032–1035.
72. Van Wamel, W.J.; Rooijakkers, S.H.; Ruyken, M.; van Kessel, K.P.; van Strijp, J.A. The innate immune
modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus
are located on beta-hemolysin-converting bacteriophages. J. Bacteriol. 2006, 188, 1310–1315. [CrossRef]
73. Peacock, S.J.; Moore, C.E.; Justice, A.; Kantzanou, M.; Story, L.; Mackie, K.; O’Neill, G.; Day, N.P. Virulent
combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect. Immun. 2002,
70, 4987–4996. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
